Concepedia

Publication | Open Access

Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy

DOIFull Paper Access

27

Citations

14

References

2018

Year

K. Patterson, Vimalanand S. Prabhu, Ruifeng Xu, Haojie Li, Yang Meng, Natalie Zarabi, Yichen Zhong, Rachael Batteson, James M. Pellissier, Stephen J. O’Keefe,
European Urology Oncology

References

YearCitations

Page 1